Leadless pacing in cardiac transplant recipients: Primary results of a multicenter case experience.
J Electrocardiol
; 60: 33-35, 2020.
Article
en En
| MEDLINE
| ID: mdl-32240867
ABSTRACT
About 4.5-20% of patients after heart transplant require pacemaker (PM) implantation. The high infective risk profile and the low probability of pacing dependency make heart-transplanted patients the ideal candidates for a leadless single-chamber PM. We report the first multicenter experience of leadless PM implantation in a series of heart-transplanted patients with a long-term follow-up. Our data confirm the feasibility and acceptable safety of leadless device in this peculiar kind of patients, despite implantation seems to be slightly more challenging with respect to non-transplanted patients. Although more data are required, a leadless single-chamber surveillance PM seems a valuable option for heart-transplanted patients.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Marcapaso Artificial
/
Trasplante de Corazón
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
En
Revista:
J Electrocardiol
Año:
2020
Tipo del documento:
Article